{
  "case_id": "Case_1_debug",
  "model_id": "google/gemini-2.5-flash",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Familial Mediterranean Fever (FMF)\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"E85.0\",\n        \"reasoning\": \"Recurrent episodes of fever, severe abdominal pain with peritoneal signs, and arthritis, especially in a patient of Somali descent, are highly suggestive of FMF. The spontaneous resolution and family history further support this.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Acute Intermittent Porphyria (AIP)\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"E80.21\",\n            \"reasoning\": \"Can cause recurrent severe abdominal pain, but typically without fever or arthritis. Neurological symptoms are common, which are not described here. However, the episodic nature and severe pain warrant consideration.\"\n        },\n        {\n            \"name\": \"Crohn's Disease (Inflammatory Bowel Disease)\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"K50.90\",\n            \"reasoning\": \"Can cause abdominal pain, fever, and arthritis. However, the acute, self-limiting nature of episodes and peritoneal signs without chronic bowel symptoms (e.g., diarrhea, weight loss) make it less likely as a primary cause but possible for episodic flares.\"\n        },\n        {\n            \"name\": \"Recurrent Peritonitis (e.g., secondary to adhesions or other chronic abdominal process)\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"K65.0\",\n            \"reasoning\": \"Could explain recurrent abdominal pain with peritoneal signs and fever, but does not explain the recurrent arthritis or strong family history of similar episodes. Spontaneous resolution is also less typical without specific intervention.\"\n        },\n        {\n            \"name\": \"Systemic Lupus Erythematosus (SLE)\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"M32.9\",\n            \"reasoning\": \"Can cause recurrent fever, polyarthritis, and serositis (including peritonitis). However, the highly episodic and self-limiting nature of the abdominal pain and lack of other systemic symptoms (e.g., rash, renal involvement) make it less likely than FMF.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent episodes of severe abdominal pain, fever (39.5\u00b0C), and arthritis (knees, ankles)\",\n        \"Episodes last 2-3 days and resolve spontaneously\",\n        \"Recent immigrant from Somalia (high prevalence region for FMF)\",\n        \"Similar episodes in family members\",\n        \"Peritoneal signs during episode\",\n        \"Elevated CRP and ESR\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Genetic testing for MEFV gene mutations\",\n            \"purpose\": \"Confirm Familial Mediterranean Fever diagnosis. This is the gold standard.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Acute phase reactants (CRP, ESR) during and between episodes\",\n            \"purpose\": \"Monitor inflammation and confirm resolution between episodes, supporting autoinflammatory disease.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Complete Blood Count (CBC) with differential\",\n            \"purpose\": \"Evaluate for leukocytosis during episodes and rule out infection.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Comprehensive Metabolic Panel (CMP)\",\n            \"purpose\": \"Assess renal and liver function, electrolytes.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Urinalysis\",\n            \"purpose\": \"Rule out urinary tract infection or renal involvement.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Abdominal Ultrasound / CT scan (if peritonitis severe)\",\n            \"purpose\": \"Rule out acute surgical abdomen (e.g., appendicitis, cholecystitis, bowel obstruction) during an episode.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Serum Amyloid A (SAA) protein\",\n            \"purpose\": \"Assess for subclinical inflammation and risk of amyloidosis, a long-term complication of FMF.\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Pain management with non-opioid options initially, considering potential for chronic pain and FMF specific treatment. Avoid narcotics if possible.\",\n            \"Antipyretics for fever control.\",\n            \"IV fluids for hydration if unable to tolerate oral intake.\",\n            \"Consultation with internal medicine/rheumatology.\",\n            \"Utilize a professional medical interpreter.\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Colchicine\",\n                \"dose\": \"0.6 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Daily (prophylactic)\",\n                \"rationale\": \"First-line treatment for FMF to prevent attacks and amyloidosis. Initiate once FMF is strongly suspected and surgical emergencies are ruled out. May be started at 0.6mg BID and titrated based on response and tolerance.\"\n            },\n            {\n                \"drug\": \"NSAIDs (e.g., Ibuprofen)\",\n                \"dose\": \"400-600 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"As needed during attacks\",\n                \"rationale\": \"For symptomatic relief of arthritis and abdominal pain during acute attacks, in conjunction with colchicine.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Vital signs (temperature, heart rate, blood pressure) every 4-6 hours during acute episode.\",\n            \"Pain level assessment frequently.\",\n            \"Input/output.\",\n            \"CRP/ESR periodically to assess disease activity and treatment response.\",\n            \"Renal function and CBC (especially WBC count) regularly, especially when on colchicine.\",\n            \"Urine for proteinuria (for amyloidosis screening) annually.\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Expertise in managing autoinflammatory diseases like FMF, long-term management, and genetic counseling.\"\n            },\n            {\n                \"specialty\": \"Medical interpreter services\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Essential for accurate history taking, patient education, and ensuring informed consent and adherence to treatment plan given language barrier.\"\n            },\n            {\n                \"specialty\": \"Social Work/Case Management\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"To assist with navigating healthcare system, access to resources, and addressing social determinants of health for a recent immigrant.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Worsening abdominal pain or new signs of peritonitis despite treatment, suggesting an acute surgical emergency.\",\n        \"Signs of systemic infection (e.g., septic shock), although FMF can mimic infection.\",\n        \"Development of new symptoms (e.g., neurological, severe rash) not typical for FMF.\",\n        \"Signs of renal impairment or significant proteinuria (suggesting amyloidosis).\"\n    ],\n    \"patient_education\": [\n        \"Explain the likely diagnosis (FMF) and its genetic basis, emphasizing it's not an infection.\",\n        \"Importance of daily colchicine adherence for preventing attacks and long-term complications (amyloidosis).\",\n        \"Symptoms of an acute FMF attack and when to seek medical attention.\",\n        \"The chronic nature of the disease and the need for ongoing medical follow-up.\",\n        \"Importance of communication regarding family planning and genetic counseling due to the hereditary nature of FMF.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1-2 weeks with Rheumatology after discharge, then every 3-6 months based on disease activity.\",\n        \"conditions\": \"Recurrence of severe symptoms, persistent fever, new or worsening joint pain/swelling, new rash, significant nausea/vomiting, or signs of colchicine toxicity (e.g., severe diarrhea, muscle weakness).\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Exact MEFV gene mutation type and its correlation with disease severity and response to treatment.\",\n        \"Presence of amyloidosis, which can be a long-term complication of untreated FMF.\",\n        \"Full extent of family history and confirmed diagnoses in relatives.\",\n        \"Patient's understanding and adherence to treatment given language and cultural barriers.\"\n    ]\n}\n```",
  "latency": 11.533716917037964,
  "timestamp": "2025-08-10T20:47:23.248366",
  "cached_at": "2025-08-10T20:47:23.248377",
  "tokens_used": 2824,
  "input_tokens": 888,
  "output_tokens": 1936
}